Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Blinatumomab As Maintenance Therapy in Patients with High-Risk B-Lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation

Tingting Zhang, Li Liu, Xiaohui Zheng, Biao Shen, Ming Gong, Xin Liu, Gang Li, Ying Zhang, Wenbin Cao, Chen Liang, Aiming Pang, Yi He, Donglin Yang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 2828.

https://doi.org/10.1182/blood-2024-209406

Published: 2024

Journal Articles

Efficacy and Safety of a Modified Conditioning Regimen Based on Mitoxantrone Hydrochloride Liposome and Busulfan/Cyclophosphamide for Patients with Refractory and Relapsed Acute Myeloid Leukemia

Chen Liang, Donglin Yang, Yi He, Aiming Pang, Xiaohui Zheng, Gang Li, Mingzhe Han, Erlie Jiang, Sizhou Feng

Blood (2024) 144 (Supplement 1): 2127.

https://doi.org/10.1182/blood-2024-205285

Published: 2024

Journal Articles

The Real-World Data of Emicizumab in Previously Untreated and Minimally Treated Patients with Hemophilia a Infants from China

Qixaun Yin, Qianqian Mao, Zhengping Li, Gang Li, Zhenping Chen, Runhui Wu

Blood (2024) 144 (Supplement 1): 5483.

https://doi.org/10.1182/blood-2024-209421

Published: 2024

Journal Articles

The R and CI Values from Thromboelastography (TEG) May be the Risk Predictors for Low-Dose Emicizumab in Chinese Pediatric Hemophilia Patients

Qianqian Mao, Zhengping Li, Qixaun Yin, Gang Li, Zhenping Chen, Runhui Wu

Blood (2024) 144 (Supplement 1): 3971.

https://doi.org/10.1182/blood-2024-211678

Published: 2024

Journal Articles

Daratumumab for Treatment of Epstein-Barr Virus-Associated Post -Transplant Lymphocyte Proliferative Disease after Rituximab Treatment Failure

Gang Li, Donglin Yang, Sizhou Feng, Erlie Jiang, Xin Liu, Chen Liang, Yi He

Blood (2024) 144 (Supplement 1): 7391.

https://doi.org/10.1182/blood-2024-207492

Published: 2024

Journal Articles

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

Dewan Zhao, Wenbin Cao, Gang Li, Ying Zhang, Xiaohui Zheng, Xin Chen, Weihua Zhai, Qiaoling MA, Rongli Zhang, Jialin Wei, Aiming Pang, Yi He, Donglin Yang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7432.

https://doi.org/10.1182/blood-2024-205145

Published: 2024

Journal Articles

A study of ruxolitinib response–based stratified treatment for pediatric hemophagocytic lymphohistiocytosis

Qing Zhang, Yun-Ze Zhao, Hong-Hao Ma, Dong Wang, Lei Cui, Wei-Jing Li, Ang Wei, Chan-Juan Wang, Tian-You Wang, Zhi-Gang Li, Rui Zhang

Blood (2022) 139 (24): 3493–3504.

https://doi.org/10.1182/blood.2021014860

Published: 2022

Includes: Supplemental data

Journal Articles

Increased prevalence of CRLF2 rearrangements in obesity-associated acute lymphoblastic leukemia

Steven D. Mittelman, Jiyoon Kim, Gordana Raca, Gang Li, Matthew J. Oberley, Etan Orgel

Blood (2021) 138 (2): 199–202.

https://doi.org/10.1182/blood.2021011106

Published: 2021

Includes: Supplemental data

Journal Articles

Escalating Single Doses of PF-05230907 (Recombinant Factor Xa Variant FXa I16L ) Are Safe and Demonstrate Hemostatic Pharmacology in Healthy Volunteers

Steven Arkin, MD, Fei Hua, PhD, Constantino Kantaridis, MD, Gang Li, PhD, Dana Parsons-Rich, MPH, MPA, Debra D Pittman

Blood (2016) 128 (22): 3781.

https://doi.org/10.1182/blood.V128.22.3781.3781

Published: 2016

Journal Articles

Tumor-Derived Chaperone-Rich Cell Lysate (CRCL) Can Be Effectively Combined with Syngeneic Bone Marrow Transplantation to Treat Bcr-abl + Leukemia in a Murine Model.

Xinchun Chen, MD, Yi Zeng, PhD, Gang Li, MD, Sylvia Thompson, Marjan Sepassi, M. Angela Romanoski, Michael W. Graner, PhD, Emmanuel Katsanis, MD

Blood (2004) 104 (11): 2971.

https://doi.org/10.1182/blood.V104.11.2971.2971

Published: 2004

NARROW

Efficacy and Safety of Blinatumomab As Maintenance Therapy in Patients with High-Risk B-Lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation

Efficacy and Safety of a Modified Conditioning Regimen Based on Mitoxantrone Hydrochloride Liposome and Busulfan/Cyclophosphamide for Patients with Refractory and Relapsed Acute Myeloid Leukemia

The Real-World Data of Emicizumab in Previously Untreated and Minimally Treated Patients with Hemophilia a Infants from China

The R and CI Values from Thromboelastography (TEG) May be the Risk Predictors for Low-Dose Emicizumab in Chinese Pediatric Hemophilia Patients

Daratumumab for Treatment of Epstein-Barr Virus-Associated Post -Transplant Lymphocyte Proliferative Disease after Rituximab Treatment Failure

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

A study of ruxolitinib response–based stratified treatment for pediatric hemophagocytic lymphohistiocytosis

Increased prevalence of CRLF2 rearrangements in obesity-associated acute lymphoblastic leukemia

Escalating Single Doses of PF-05230907 (Recombinant Factor Xa Variant FXa I16L ) Are Safe and Demonstrate Hemostatic Pharmacology in Healthy Volunteers

Tumor-Derived Chaperone-Rich Cell Lysate (CRCL) Can Be Effectively Combined with Syngeneic Bone Marrow Transplantation to Treat Bcr-abl + Leukemia in a Murine Model.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only